Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseaseMichał Pawlak, Bart Staels|Journal of Hepatology|2014Cited by 1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1Philippe Delerive, Bart Staels|Journal of Biological Chemistry|1999Cited by 1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Velimir A. Luketic, Juan F. Gallegos‐Orozco et al.|Gastroenterology|2016Cited by 1k
PPAR control of metabolism and cardiovascular functionsDavid Montaigne, Bart Staels|Nature Reviews Cardiology|2021Cited by 901
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis SocietyHenry N. Ginsberg, Alberico L. Catapano, Chris J. Packard et al.|European Heart Journal|2021Cited by 889